The Annual Regulatory Plan for 2023 recently released by the Spanish Government provides for important regulatory changes and developments in the area of medicinal products, including pricing and reimbursement or health...more
The Spanish Agency for Medicinal Products and Medical Devices (AEMPS) stated that it will not take, for the time being, any regulatory action to temporarily suspend or halt the recruitment of patients for clinical trials to...more
Spain’s Ministry of Health initiated proceedings for approval of the new regulation on medical devices with a call for a prior public consultation to receive contributions from interested parties....more
3/3/2020
/ Clinical Laboratory Testing ,
EU ,
Healthcare Reform ,
Life Sciences ,
Medical Devices ,
New Regulations ,
Pharmaceutical Distribution ,
Pharmaceutical Industry ,
Public Consultations ,
Regulatory Agenda ,
Regulatory Oversight ,
Regulatory Requirements ,
Regulatory Standards ,
Rulemaking Process ,
Spain